Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses
J Thorac Dis
.
2016 Sep;8(9):E1034-E1040.
doi: 10.21037/jtd.2016.08.79.
Authors
William B Hillegass
1
,
Gregory S Bradford
1
Affiliation
1
Heart South Cardiovascular Group, Brookwood Shelby Baptist Medical Center, Department of Biostatistics, University of Alabama at Birmingham, Alabaster and Birmingham, Alabama, USA.
PMID:
27747056
PMCID:
PMC5059288
DOI:
10.21037/jtd.2016.08.79
No abstract available
Publication types
Comment